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Abstract
Rationale Parkinson’s disease (PD) impairs working memory (WM)—the ability to maintain items in memory for short periods
of time and manipulate them. There is conflicting evidence on the nature of the deficits caused by the disease, and the potential
beneficial and detrimental effects of dopaminergic medication on different WM processes.
Objectives We hypothesised that PD impairs both maintenance and manipulation of items inWM and dopaminergic medications
improve this in PD patients but impair it in healthy older adults.
Methods We tested 68 PD patients ON andOFF their dopaminergic medication, 83 healthy age-matched controls, and 30 healthy
older adults after placebo and levodopa administration. We used the digit span, a WM test with three components (forwards,
backwards, and sequence recall) that differ in the amount of manipulation required. We analysed the maximum spans and the
percentage of lists correctly recalled, which probe capacity ofWMand the accuracy of the memory processes within this capacity,
respectively.
Results PD patients had lower WM capacity across all three digit span components, but only showed reduced percentage
accuracy on the components requiring manipulation (backwards and sequence spans). Dopaminergic medication did not affect
performance in PD patients. In healthy older adults, levodopa did not affect capacity, but did impair accuracy on one of the
manipulation components (sequence), without affecting the other (backwards).
Conclusions This suggests that the deficit of maintenance capacity and manipulation accuracy in PD patients is not primarily a
dopaminergic one and supports a potential Boverdosing^ of intact manipulation mechanisms in healthy older adults by levodopa.
Keywords Parkinson’s disease . Dopamine .Workingmemory . Levodopa . Short-termmemory
Abbreviations
PD Parkinson’s disease
WM working memory
HC healthy control
MoCA Montreal Cognitive Assessment
DASS Depression, Anxiety and Stress Scale
BIS Barratt Impulsivity Scale
LARS Lille Apathy Rating Scale
LDE levodopa dose equivalency
MDS-UPDRS-III Movement Disorder Society Unified
Parkinson’s Disease Rating
Scale section III
Introduction
Working memory (WM) involves the maintenance and manip-
ulation of elements held in memory for short periods of time.
Early models suggested WM is composed of phonological and
visuospatial storage components, and a central executive that
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manages attentional demands and the manipulation of stored
elements (Baddeley 2012; Baddeley and Hitch 1974).
Parkinson’s disease (PD) has been associated with im-
paired WM, especially for visuospatial tasks or complex tasks
requiring manipulation (Hoppe et al. 2000; Lewis et al. 2005;
Werheid et al. 2002). Maintenance of WM is also impaired in
PD (Fallon et al. 2017a), though a meta-analysis of 56 WM
span studies suggested that verbal maintenance was reduced
to a lesser extent than verbal manipulation, and that spatial
WM was impaired the most (Siegert et al. 2008).
Maintenance processes have been linked to parietal regions
(Aboitiz et al. 2010; Müller and Knight 2006; Smith and
Jonides 1997) and manipulation to prefrontal regions
(Müller and Knight 2006; Smith and Jonides 1997). PD af-
fects prefrontal regions before parietal (Braak et al. 2003), due
to the greater dopaminergic innervation of the former
(Yetnikoff et al. 2014), which could explain the greater deficits
in manipulation processes.
Dopaminergic medication might improve both mainte-
nance and manipulation in PD patients (Beato et al. 2008;
Owen et al. 1997; Zokaei et al. 2015), though some tasks have
found no effect of medication (Cooper et al. 1993; Fournet
et al. 2000; Zokaei et al. 2015) or only shown benefits in
specific subgroups such as patients with low baseline WM
(Warden et al. 2016) or in patients with onset of motor symp-
toms on their left-side (Hanna-Pladdy et al. 2015).
Importantly, the sample sizes of many of these studies are
relatively small (n = 7–28), meaning they are only able to
detect medium or large effect sizes. This may have contributed
to the conflicting results.
Dopamine can also impair WM, perhaps due to an
overdosing of intact areas of the brain (Cools and D’Esposito
2011). This is more often seen in healthy participants than pa-
tients (Bloemendaal et al. 2015; Fallon et al. 2017b), although
benefits of dopamine are also seen (Fallon et al. 2017b; Luciana
et al. 1989; Naef et al. 2017) as are no-effects (Linssen et al.
2012); this may reflect different optimal levels of dopamine for
different functions within WM such as maintenance and ma-
nipulation. Interestingly, in one of these studies testing WM
following administration of methylphenidate (a dopamine and
noradrenaline reuptake inhibitor), both beneficial and deleteri-
ous effects were demonstrated in the same group of participants
(Fallon et al. 2017b); methylphenidate improved distractor re-
sistance on a spatialWM task, but impaired flexible updating of
information held in WM. This suggests that the Boverdose^
effects reported in some studies may not be seen when using
broadmeasures ofWMbut require specific measurement of the
different underlying processes.
We hypothesised that PD would impair maintenance and
manipulation of WM, and that dopaminergic medication
would remediate the deficits in PD patients while
Boverdosing^ and impairing WM in healthy older adults. We
used a simple WM measure, the digit span (Wechsler 2008),
which is commonly given in neuropsychological assessments.
We used three variations of the digit span (forwards, back-
wards, sequence recall) with different contributions of main-
tenance and manipulation processes. This was given to a large
sample of PD patients ON and OFF their normal dopaminer-
gic medication and healthy age-matched controls (HC), and a
separate group of healthy older adults after administration of
placebo or levodopa.
Methods
Ethical approval
Data are presented from several different studies running un-
der different ethical approvals. Experiment 1 studies were ap-
proved by Frenchay and Southwest Central Bristol NHS
RECs. Experiment 2 was approved by University of Bristol
Faculty REC. All procedures were carried out in accordance
with the relevant guidelines and regulations. All participants
gave written informed consent, in accordance with the
Declaration of Helsinki.
Participants
Experiment 1
Demographic details for all groups are presented in Table 1.
To generate a good sample size, we applied a robust, con-
sistent protocol for testing digit span across several different
studies. In total, we collected data from 68 PD patients and 83
HC who all performed the digit span (as well as other cogni-
tive tasks dependent on the study). Patients with a diagnosis of
idiopathic PD were recruited from neurology and movement
disorder clinics at Southmead and Frenchay Hospitals in
Bristol, UK. All were taking levodopa and/or dopamine re-
ceptor agonists, were not taking irreversible mono-amine ox-
idase inhibitors or acetylcholinesterase inhibitors, and did not
have deep-brain stimulators implanted. They had no serious
neurological disorders other than PD and had normal or
corrected vision and hearing.
HC were recruited from our healthy volunteer database.
They were 55 years or older, had no neurological disorders,
were not taking dopaminergic medications, and had normal or
corrected to normal vision and hearing.
Experiment 2
We recruited 35 healthy older (65+ years) adults from volun-
teer databases and Join Dementia Research databases. The
same inclusion/exclusion criteria as for the HC group above
were used, as well as contraindications and medical exclu-
s ions per ta in ing to the drugs adminis tered (see
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Supplementary Materials 1 for full exclusion criteria). Two
participants withdrew before completing one session, and
three withdrew before completing both the drug and placebo
session, leaving data from 30 participants analysed here.
Procedure
In the digit span, the experimenter reads aloud a list of
digits at a rate of one per second and the participant must
repeat the list back. All digits must be in the correct order
for the list to be marked correct. The lists start at a length
of two digits, and two lists of each length are read out.
The list lengths increase by one digit until the participant
gets both lists of the same length correct.
There are three components of the digit span: in the
forwards span, the list must be recalled in the same order
as said by the experimenter; in the backwards span, par-
ticipants must repeat it in the reverse order to presentation
order; in the sequence span, participants must recall the
list in ascending numerical order. Forwards and sequence
components present two lists of each length from 2 to 9
digits. The backwards component presents four lists of
two digits length, then two lists from lengths of 3–8
digits. There are 16 lists in total for each component.
Experiment 1
PD patients completed the three components (forwards, back-
wards, sequence) of the digit span once ON and once OFF
medication (medication order randomised and counterbalanced),
while HC completed it once.When comingOFFmedication, PD
patients were withdrawn from standard release dopaminergic
medication for a minimum of 16 h and from long-lasting dopa-
minergic medications for a minimum of 24 h.
Experiment 2
This was a within-subjects double-blinded, placebo-
controlled study. The participants completed both the drug
and placebo conditions, in a randomised, counterbalanced
order.
Healthy older adults received 10 mg/ml domperidone or a
placebo, followed by 187.5 mg co-beneldopa (150 mg levo-
dopa, 37.5 mg benserazide) or a second placebo. Neither par-
ticipant nor experimenter knew on which visit the participant
received the drug or placebo. Their heart rate and blood pres-
sure were monitored before and after administration. After
1.5 h, they completed the digit span, along with other cogni-
tive tests.
Table 1 Demographics of participants tested in Experiments 1 and 2.
Statistical comparisons are against HC from Experiment 1 (standard
deviations in parentheses, range in square brackets). The older adults
from Experiment 2 did not differ from the HC in Experiment 1 on any
measure (p > .05). Three HC did not complete the MoCA
Measure PD Experiment 1 HC Experiment 1 HC Experiment 2
Number 68 83 30
Age 68.40 (6.53) [55–85] 69.66 (8.49) [48–93] 70.67 (6.83) [65–92]
Gender (M:F) 49:19* 39:44 14:16
MoCA 25.31* (2.88) [18–30] 26.94 (2.37) [20–30] 26.23 (3.15) [18–30]
MoCA > 25:25–21:< 21 37:26:5* 60:19:1 18:10:2
Years education 13.70 (3.19) [9–25] 14.65 (2.87) [7–21] 14.33 (3.48) [10–24]
DASS 22.91* (16.78) [4–64] 14.07 (18.27) [0–94] 11.27 (10.29) [1–39]
BIS 54.04 (8.50) [38–69] 50.33 (9.00) [31–77] 48.50 (8.54) [31–66]
LARS − 22.71* (4.81) [− 29 to − 13] − 27.28 (4.57) [− 33 to − 16] − 26.60 (5.54) [− 34 to − 14]
LDE 605.41 (353.89) [150–1746]
Years symptoms 5.79 (3.86) [1–18]
Years diagnosed 4.63 (3.47) [1–14]
MDS-UPDRS-III ON 27.88+ (13.36) [6–62]
MDS-UPDRS-III OFF 32.85 (13.53) [7–69]
MoCA, Montreal Cognitive Assessment;DASS, Depression, Anxiety and Stress Scale; BIS, Barratt Impulsivity Scale; LARS, Lille Apathy Rating Scale;
LDE, levodopa dose equivalency; MDS-UPDRS-III, Movement Disorder Society Unified Parkinson’s Disease Rating Scale section III
*p < .05 for PD vs HC
+ p < .05 for PD ON vs PD OFF
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Data analysis
We used several scoring measures for the digit span to capture
different sources of errors. The maximum span length correct-
ly recalled gives a measure of the maximum capacity of a
participant’s WM. This is calculated for each span component
(forwards, backwards, and sequence) separately.
People can also make errors even before they have hit their
capacity limit, which is not picked up by the maximum span
measure. There are several measures sensitive to the number
of errors in WM which reflect WM accuracy rather than
capacity. The number of lists recalled correctly gives a simple
count of these errors but is confounded by the fact that people
with smaller capacities will exit the test earlier and thus not
attempt as many lists as someone with a larger span.
Therefore, we analysed the percentage of lists recalled correct-
ly, which corrects for the number of lists attempted and gives a
more reliable and accurate measure of the accuracy of WM
(Conway et al. 2005; Friedman and Miyake 2005).
Assessing the percentage of digits recalled correctly rather
than the lists may have even greater reliability and sensitivity
as it captures extra information in the data (Friedman and
Miyake 2005; Unsworth and Engle 2007). Unfortunately,
the exact digits recalled were not consistently recorded for
all participants; there are only digit error data for 45 PD and
52 HC from Experiment 1, and only for two participants from
Experiment 2. These data are presented in Supplementary
Materials 2 but are not reported here due to the much lower
power and weaker effects.
As these measures are all calculated from the same set of
data, we looked at the correlation matrix between them. There
were weak or moderate correlations between most of the mea-
sures, although some of the correlations with the % digits
correct measure were not significant (see Table S5 for values).
Q-Q plots showed that the spans were all approximately
normal. Between-subject ANOVAs and t tests were used to
compare PD patients and HC, and within-subject t tests to
compare the effect of medications on PD patients and the
effect of levodopa on healthy participants in Experiment 2.
When comparing the three components, Bonferroni correc-
tions were applied (α = 0.0167). Data were analysed using
SPSS (IBM, version 23.0).
Data availability
Experiment 1 did not obtain consent to share individual
participants’ data, so we are not able to publish or pro-
vide the data without further permission from our study
sponsor.
Anonymised data fromExperiment 2 are available from the
University of Bristol’s data repository, data.bris, at https://doi.
org/10.5523/bris.15du56inneqal1ys8rhzuhbmmu (Grogan
et al. 2018).
Results
Experiment 1
PD patients had lower capacities (maximum spans) for for-
wards (F (2, 216) = 4.572, p = .011, η2p = .041), backwards (F
(2, 216) = 6.590, p = .002, η2p = .058), and sequence (F (2,
216) = 8.317, p < .001, η2p = .072) components, with greater
effect sizes in the manipulation spans (backwards and
sequence spans; see Fig. 1 and Table 2). Paired t tests showed
no significant differences between PD ON and OFF dopami-
nergic medication on any component (forwards: t (67) = 0.944,
p = .348, d = 0.102; backwards: t (67) = − 0.309, p = .758, d =
0.032; sequence: t (67) = 0.456, p = .650, d = 0.049).
PD patients had lower accuracy (i.e., lower percentage of
lists correct) than HC only for the manipulation components
(see Fig 2; backwards: F (2, 216) = 9.060, p = .0002, η2p
= .077; sequence: F (2, 216) = 6.410, p = .0020, η2p = .056)
but not for the forwards component (F (2,216) = 1.818,
p = .1648, η2p = .017). Dopaminergic medication did not affect
the accuracy for any component (forwards: t (67) = − 1.236,
p = .2208, d = 0.147; backwards: t (67) = 2.011, p = .0483,
d = 0.281; sequence: t (67) = 1.436, p = .1556, d = 0.167).
As PD patients had lower capacity on the forwards compo-
nent but did not have lower accuracy, we compared these two
measures directly to see whether we could conclude that PD
only affected capacity and did not affect accuracy (this conclu-
sion is not possible from one significant effect and one non-
significant effect). We also applied this comparison to the other
two components.We converted capacity into a percentage to be
on the same scale as the percentage of lists correct and ran a
mixed ANOVA (within-subject factor: measure type; between-
subject factor: group (PD or HC)). The forwards component
had a significant measure * group interaction (F (1, 217) =
6.511, p = .011, η2p = .029) that passed the Bonferroni-
Fig. 1 ThemeanWM capacity (maximum spans) for PD patients ON and
OFF dopamine, HC, and healthy older participants on levodopa and
placebo on each component of the digit span (SEM bars). PD patients
had lower capacities than HC for all span components, but there were no
effects of dopamine for PD patients or healthy older adults for any
component. *p < .01667 (Bonferroni-corrected threshold), **p < .001667
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corrected threshold (α = .01667), while backwards (F (1,
217) = 4.641, p = .032, η2p = .021) and sequence (F (1, 217) =
4.984, p = .027, η2p = .022) did not. This suggests that PD af-
fects the capacity and accuracy differently for the forwards
component, but not the backwards or sequence components.
Post-hoc tests
We performed post-hoc exploratory tests to examine the types
of errors people were making. The different types of errors
made were scored using a method adapted from Woods et al.
(2011a; see Supplementary Materials 3 for procedure and
examples). In brief, the number of different types of order
errors (swaps and permutations) and number errors (substitu-
tions, omissions, intrusions) was scored. These were convert-
ed to percentages by dividing them by the number of digits
attempted and multiplying by 100. These were not analysed
for Experiment 2 as there were only two participants with all
digits recorded (see BMethods^ section).
We found that order errors were increased in PD patients
only for the backwards span (p = .0004), not forwards
(p = .3473) or sequence spans (p = .1187). There were no dif-
ferences between PD ON and OFF (p > .1). Other types of
errors (substitution, omission, intrusion) were not different
between the groups (p > .05) or medication conditions
(p > .0167).
We also examined the influence of cognitive function (and
other factors) on the PD results. PD patients with a large range
of MoCA scores were included in the analysis, and we found
no correlation between MoCA and the difference in digit span
measures ON and OFF medication. We also split the partici-
pants into high and low cognitive function groups (MoCA ≥
26) and ran ANOVAs with this included as a between-subject
factor. No interactions between this factor and group or med-
ication state were found.
We ran similar analyses for the duration of disease, UPDRS
scores, levodopa dose equivalency, laterality of motor symp-
toms, and other questionnaire scores mentioned in Table 1, but
found no signif icant associat ions (p > .0167, see
Supplementary Materials 2 for details).
Experiment 2
Looking at the healthy older adults given levodopa and place-
bo, levodopa did not affect WM capacity for any component
(forwards: t (29) = 0.516, p = .610, d = 0.070; backwards: t
(29) = 0.311, p = .758, d = .051; sequence: t (29) = − 0.0124,
p = .920, d = 0.028) (see Fig 1 and Table 2).
However, levodopa did decrease the accuracy for the se-
quence component (t (29) = − 2.919, p = .007, d = 0.689),
though not for the forwards (t (29) = − 0.453, p = .654, d =
0.072) or backwards (t (29) = − 0.452, p = .654, d = 0.085)
Table 2 Effect sizes and p values from group comparisons of digit span
measures. Between-subject one-way ANOVAswere used to compare HC
vs PD ON vs PD OFF, while paired t tests were used to compare PD ON
vs PDOFF andDrug vs Placebo. Bonferroni corrections were applied at a
significance threshold of α = .01667
Comparison Measure Forwards Backwards Sequence
d p value d p value d p value
HC vs PD ON vs PD OFF Max span 0.414 0.011358* 0.496 0.001667** 0.557 0.000331**
% lists correct 0.263 0.164839 0.578 0.000167*** 0.487 0.001975*
PD ON vs PD OFF Max span 0.102 0.348482 0.032 0.758273 0.049 0.650100
% lists correct 0.147 0.220807 0.281 0.048302 0.167 0.155641
Drug vs placebo Max span 0.070 0.609901 0.051 0.757700 0.028 0.902247
% lists correct 0.072 0.654236 0.085 0.654438 0.689 0.006718*
*p < .0167
**p < .00167
***p < .000167
Fig. 2 The mean WM accuracy (percentage of lists correct) for each
group, on each digit span component (SEM bars). PD patients had
lower accuracy scores for the backwards and sequence components but
not the forwards component. Dopamine did not affect accuracy in PD
patients, but levodopa did decrease accuracy on the sequence component
for healthy older adults. *p < .01667 (Bonferroni-corrected threshold),
***p < .0001667
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components (see Fig 2). No effects of weight-adjusted levo-
dopa dose were seen (see Supplementary Materials 2).
Only two participants from Experiment 2 had their error
responses recorded, so the percentage of digits correct were
not analysed for Experiment 2.
Discussion
PD patients had lower averageWM capacity than HC for each
component of the digit span, as well as lower average accura-
cy for backwards and sequence components. A post-hoc anal-
ysis also revealed that PD patients made more transposition
errors on the backwards component of the digit span.
Dopaminergic medication did not affect performance on any
component or measure in PD patients. In healthy older adults,
levodopa did not affect capacity, but did decrease the accuracy
for the sequence component.
PD patients were only worse on the maintenance compo-
nent (forwards digit span) whenmeasuring the maximum span
length recalled, not the percentage of lists correct. However,
for the manipulation components (backwards and sequence
spans) PD impaired the maximum capacity and percentage
of lists correct similarly. The two measures were moderately
correlated, with the forwards component showing the stron-
gest correlation between capacity and accuracy. Despite this,
the forwards component was the only component to have a
significant group * measure interaction, suggesting that only
this component was differently affected by PD.
This distinction suggests that the two measures are tapping
into distinct processes during WM—the capacity and the ac-
curacy. It also suggests that PD impairs the capacity for main-
tenance and manipulation processes, but only reduces accura-
cy of manipulation processes. This aligns with previous liter-
ature which has suggested that while PD does lead to more
decay of precision of items held in memory (Fallon et al.
2017a; Zokaei et al. 2015), there are greater deficits when
manipulation is required (Lewis et al. 2005) and that this is
due to increased number of errors (Fallon et al. 2017a).
Alternatively, the difference in the measures may simply
reflect poorer sensitivity of the accuracy measure. However,
previous literature suggests that the percentage accuracy
scores actually have greater sensitivity and reliability than
simpler measures such as the maximum span length
(Conway et al. 2005; Friedman and Miyake 2005), which
would argue against this view.
The general deficit in WM capacity across components
could reflect a reduction in the number of items that can be
maintained in WM having a knock-on effect onto the manip-
ulation components in the backwards and sequence compo-
nents. The three components are not completely independent
measures as shown by the moderate correlations between
them (see Supplementary Materials 2). If PD reduces the
number of items a person can hold in their memory, then this
would also reduce the maximum spans possible in the back-
wards and sequence components. This is unlikely to be the
sole driver of this deficit however, as backwards and sequence
components had lower mean maximum spans than the for-
wards component, meaning they were not hitting the ceiling
imposed by the maintenance capacity and that there is an extra
source of error in these manipulation components.
If PD harms WM but dopaminergic medication does not
improve it, then a non-dopaminergic pathology is suspected.
PD patients have alterations to many neuromodulatory sys-
tems including noradrenaline, acetylcholine, and serotonin
(Jellinger 1991; Scatton et al. 1983), which may underlie the
deficit. Alternatively, it could be a dopaminergic pathology,
but simply one that is too severe to be repaired by dopamine
replacement therapy, although this seems unlikely given that
motor symptoms, usually seen before cognitive changes, are
still helped by dopaminergic medication, as evident in the
reduced UPDRS scores in PD patients when ON medication.
More interesting is the apparent sparing of maintenance ac-
curacy from the WM manipulation accuracy deficit caused by
PD. This could suggest that the underlying processes account-
ing for errors on the spans is different when manipulation of the
items is required, as PD seems to reduce the maximum number
of items that can be maintained in WM, without increasing
errors made. To explain this, we invoke the multicompartment
model of WM (Baddeley 2003), which posits a phonological
loop for storage of items, and a central executive that mediates
manipulation of items stored. We propose that PD impairs the
capacity of the phonological loop, without increasing errors in
storage under this limit, and also impairs the central executive’s
ability to interact with items stored.
Our exploratory analysis of the types of errors made found
that PD patients made more order errors than HC for the back-
wards component only. Looking for order errors in the sequence
component does notmakemuch sense as the participants recalled
the digits in numerical order, so did not have to remember the
position of the digits during presentation. Order errors in this
component were very rare, and likely reflect something entirely
different to a transposition error in the other two components.We
believe that this pattern of results suggests that PD patients make
more order errors when manipulation is required, but that this is
hidden when they recall the digits in numerical order. This could
suggest that PD patients are more prone to Bmisbinding^ items
and locations when manipulation is required. This would contra-
dict several studies examining misbinding in PD patients using
continuous measures of error, which find PD patients do not
differ in the amount of misbinding to HC (Fallon et al. 2017a;
Zokaei et al. 2014, 2015).
Alternatively, it is possible that patients are actually Bover-
binding^, which prevents them from reversing the order of
those items when reversing the entire list. The majority of
the order errors were Bswap errors^ where two digits are
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swapped (e.g. the correct answer 12345 becomes 12435). In
the backwards component (where the presented list would
have been 54321), this could be either because the participants
have swapped the items around and then reversed the list, or
they reversed the list except for those two items which Bstuck^
in their relative order.
The pattern of results from Experiment 2 suggests that
levodopa does not affect the maximum capacity of any of
the digit span components but may reduce the accuracy only
for the sequence span. This induced deficit supports the dopa-
mine overdose hypothesis which posits that dopaminergic
drugs will overdose intact functioning in the brain, leading
to impairments (Cools and D’Esposito 2011). That manipula-
tion accuracy was reduced by levodopa corroborates reports
that methylphenidate impairs the flexible updating of WM
information (Fallon et al. 2017b), which would be needed in
the sequence span. However, this effect should be interpreted
with caution; unlike the pattern of effects seen in PD patients,
this one is isolated. There was no impairment on the other
manipulation component (the backwards span). Therefore,
while it may be that levodopa does impair manipulation accu-
racy of WM items, it is also possible that this is simply an
artefact or false positive.
There are several drawbacks in using the digit span that
should be considered. As only two lists of each length are
presented, it provides a very noisy measure of performance.
Adapted versions presented via computer are available which
use repeated presentations of list lengths, and do not exit when
they fail to recall the lists, but instead decrease the length and
then increase it back up if they recall that one correctly
(Woods et al. 2011b). This step-up/step-down procedure is
more sensi t ive to people’s maximum capaci t ies .
Computerised assessment would also rule out any variability
induced by slightly different speaking speeds, accents, vol-
ume, and diction, from different experimenters, which may
have affected performance. Other computerised tasks are
available which provide analogue error measures on WM,
which have shown far greater sensitivity than the digit span
(Zokaei et al. 2015). Work with these tasks has suggested that
WM capacity may not be determined by the number of dis-
crete Bslots^ for information but rather by the allocation of a
shared capacity resource (Bays et al. 2009; Schneegans and
Bays 2016). Future work with these more sensitive tasks will
be able to separate out the specificWM processes impaired by
PD and affected by dopamine. These could be used to test
predictions from this study, such as PD impairs WM mainte-
nance and manipulation capacity but not maintenance accura-
cy, while dopamine does not remediate this deficit in PD but
may Boverdose^ manipulation accuracy in healthy controls.
In summary, PD impaired maximum capacity of mainte-
nance spans, and the capacity and accuracy of manipulation
spans. Despite this, PD patients show no benefit of dopami-
nergic medication on maintenance or manipulation of WM,
suggesting that the deficit is not wholly dopaminergic.
Levodopa also did not affect WM capacity in healthy older
adults, but may have decreased accuracy on manipulation
span, although this effect should be viewed with caution.
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